Compare McKesson Corporation (MCK) vs United Airlines Holdings Inc (UAL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
McKesson Corporation vs United Airlines Holdings Inc — how do they compare? McKesson Corporation trades at $829.3 (market cap $97.35B), while United Airlines Holdings Inc trades at $117.72 (market cap $38.15B). The key difference: McKesson Corporation is far larger — about 2.6× United Airlines Holdings Inc's market cap, and McKesson Corporation pays a 0.39% dividend while United Airlines Holdings Inc pays none. Which is the better fit depends on your goals.
| MCK | UAL | |
|---|---|---|
Market Cap | $97.35B | $38.15B |
Sector | Health | Industrials |
52-Week High | $995.69 | $136.11 |
52-Week Low | $659.01 | $84.57 |
Enterprise Value | $101.98B | $55.18B |
Dividend Yield | 0.39% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
McKesson Corporation (MCK) trades at $831.60, down 1.16% on the day, with a bullish technical signal and positive earnings momentum after beating estimates for three consecutive quarters. The stock shows strong analyst support with an 80% buy rating and a consensus price target of $932.83, implying potential upside. Revenue growth is robust, reaching $359.05 billion in 2025, though net margins remain thin at 1.18%. Cash flow from operations improved to $6.09 billion in 2025, supporting financial stability.
The outlook for MCK is positive, driven by earnings beats, analyst optimism, and solid cash generation. Key opportunities include growth in specialty pharma and oncology services. Risks involve policy uncertainties, competitive pressures, and execution challenges. The stock's current price near key support at $829 suggests a critical level for near-term direction.
United Airlines (UAL) trades at $116.77, up 1.18% with a bullish technical signal despite mixed moving averages. The company shows strong fundamentals with a P/E of 10.81 and consistent earnings beats, including Q2 2026 EPS of $1.99 versus $1.88 expected. Revenue growth is robust, rising to $59.07B in 2025, though fuel costs pose headwinds. Analyst consensus is strongly bullish with a $163.75 price target and no sell ratings among 47 analysts.
Outlook remains positive due to resilient travel demand and premium revenue growth, but investors face risks from volatile fuel prices and operational disruptions. The stock offers value with low valuation multiples and upward earnings revisions, yet macroeconomic sensitivity requires caution.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About McKesson Corporation
McKesson is a leading wholesaler of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and Cardinal Health, the three account for well over 90% of the U.S. pharmaceutical wholesale industry. McKesson is currently divesting from its pharmaceutical wholesale and distribution in Europe and Canada in order to redeploy capital to strategic growth areas in the U.S. (oncology network and ecosystem, and biopharma services). Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
Read more on MCK →About United Airlines Holdings Inc
United Airlines is a major U.S. network carrier. United's hubs include San Francisco, Chicago, Houston, Denver, Los Angeles, New York/Newark, and Washington, D.C. United operates a hub-and-spoke system that is more focused on international travel than legacy peers.
Read more on UAL →
